Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HepZero:Heparin Free Dialysis With Evodial: A Prospective Multicenter, Open, Randomized, Controlled Clinical Study With Parallel Groups

NCT01318486 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.

NCT NCT01318486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HepZero:Heparin Free Dialysis With Evodial: A Prospective Multicenter, Open, Randomized, Controlled Clinical Study With Parallel Groups
Lead sponsor
Vantive Health LLC
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2011
Completion date
February 28, 2013
Enrollment
265 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, patients requiring heparin free dialysis treatments